Sarah-Kim Friedrich-Becker
Company: Abalos Therapeutics
Job title: Senior Principal Scientist
Seminars:
Addressing the Current State of Novel Viral Platforms in Oncology To Demonstrate Increased Therapeutic Potential 9:00 am
Overview of traditional and novel oncolytic and non-oncolytic viral platforms Understanding their advantages and unique characteristics Engineering a non-oncolytic immuno-virotherapy based on Lymphocytic Choriomeningitis Virus with enhanced tumour cell targetingRead more
day: Day One